Long-term ASCs of various specificities established in the BM during previously resolved infections are expected to have the highest surface abundance of CXCR4 and of the integrins α4 and β1; accordingly, they are less likely to be substituted by arriving ASCs with fresh specificities generated in the ongoing response. The gene discussed is CXCR4; the disease is infection.